Dear Colleagues,

Metabolic and energetic disturbances have recently been considered not only as a consequence, but also as one of the causes of neurodegeneration. A well-known attribute of neurodegenerative diseases, such as in Alzheimer's disease, Parkinson's disease and others, is the progressive loss of neurons. Despite the fact that the causes of these diseases can be polyetiological, they have a wide range of similar molecular and cellular pathophysiological processes, namely protein aggregation, glutamate toxicity, calcium, proteolytic and oxidative stress, neuroinflammation, mitochondrial dysfunction, hormonal changes and others, associated with aging.

Neurodegenerative diseases are age dependent, so their development is closely related to common aging mechanisms and metabolic lesions. Cell cultures, animal models, and human studies show close connection between neurodegeneration and metabolic alterations, namely, obesity, glucose metabolism disturbances, and impairments in hormone secretion, including melatonin, leptin, ghrelin, etc. Although many have known about the pathogenesis of neurodegenerative diseases, they still do not have a therapy capable of stopping the progression and modern methods are directed at the symptoms of the disease.

This Special Issue aims to highlight the numerous metabolic changes in neurodegenerative diseases and related current therapeutic approaches.

Dr. Sandeep Singh
Prof. Dr. Soraya L. Valles
Dr. Burkhard Poeggeler
Dr. Anastasiia D. Shkodina
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Parkinson’s disease
• Alzheimer’s disease
• metabolism
• metabolites
• hormones
• inflammation
• neurodegeneration
• drug discovery
• therapy